New Disputas Announced – Dr Vegar Dagenborg
Dr Vegar Dagenborg from Kjersti Flatmark’s Translational Cancer Therapy group has successfully submitted his thesis entitled “Molecular and immune landscape
Read moreDr Vegar Dagenborg from Kjersti Flatmark’s Translational Cancer Therapy group has successfully submitted his thesis entitled “Molecular and immune landscape
Read moreThe Metimmox trial, which has been running at Norwegian hospitals (Akershus University Hospital, St. Olav’s University Hospital, Haukeland University Hospital,
Read moreCMOR members Erta Kalanxi, Sebastian Meltzer and Anne Hansen Ree have published a new review article looking into the current
Read moreIn a new study titled “Immune stimulatory effect of anti-EpCAM immunotoxin – improved overall survival of metastatic colorectal cancer patients”,
Read moreImmune effectors in colorectal cancer. A recent publication from ACREDIT describes how systemic release of osteoprotegerin during oxaliplatincontaining induction chemotherapy
Read moreAnne Hansen Ree and Svein Dueland were both awarded important grants from the Norwegian Cancer Association (Kreftforeningen). Anne Hansen Ree’s
Read moreAcredit member Sebastian Meltzer presents his research about how chemotherapy can kick-start the immune system at forskning.no LINK
Read more